By health condition
By demographic
Each summary is provided by the external research team. The views expressed may not reflect those of the NIHR BioResource.
We’ve also created a few study collections:
Studies 343-351 of 422
IBD drug therapies and COVID-19
Speciality areaGastroenterology, Infection, COVID
Study typeData only
Researcher typeAcademic
Research leadNick Kennedy
Investigation of the underlying genetic variation of idiopathic and heritable pulmonary arterial hypertension (PAH)
Speciality areaGenomics and Rare Diseases, Cardiovascular Disease
Research leadDr Stefan Gräf
CLARITY: impaCt of bioLogic therApy on saRs-cov-2 Infection and immuniTY
Speciality areaInfection, COVID
Study typeParticipant re-contact
Research leadDr Tariq Ahmad
TRACK-COVID: a population-based epidemiological investigation of COVID-19 virus infection
Speciality areaCross-cutting, COVID
Research leadProfessor Emanuele Di Angelantonio
COVID19 pneumonitis
Speciality areaRespiratory Disorders, COVID
Research leadDr Charles Crawley
Investigating polygenic risk for immune-mediated disease in a sporadic primary immunodeficiency cohort.
Speciality areaGenomics and Rare Diseases
Research leadHannah Huang
BRIDGE- EDS (Ehlers-Danlos Syndrome)
Research leadHeather Cordell
Genetic Links to Anxiety and Depression (GLAD) Study
Speciality areaGenomics and Rare Diseases, Mental Health
Research leadGerome Breen
Paediatric Bone Marrow Failure Syndromes (Stem Cell and myeloid disorders)
Speciality areaGenomics and Rare Diseases, Children and Young People
Research leadProf. Adam Mead